- News- Around the world in 24 hours: A snapshot of COVID’s global havoc- October 26, 2020- Some medical societies feature sessions at their annual meetings that feel like they’re 24 hours long, yet few have the courage to schedule a session that runs all day and all night. 
- News- Unneeded meds at discharge could cause harm- October 26, 2020- The problem stems from a technology disconnect when patients are transferred from the ICU to the general population. 
![1]() - News- Score predicts risk for ventilation in COVID-19 patients- October 23, 2020- “If mild COVID disease in young patients caused cardiac injury, you can imagine what it can do to older patients with severe disease,” Dr. Alnababteh said. 
![1]() - News- Trump and Biden face off over COVID-19, ACA in final debate- October 23, 2020- The adequacy of the COVID-19 response to date, the likely timeline for vaccine availability, and how to reopen businesses were among the points on which the two candidates disagreed. 
![1]() - News- When should students resume sports after a COVID-19 diagnosis?- October 23, 2020- While many patients will be ready to gradually return to play after quarantining, cardiac symptoms should prompt additional evaluation. 
![1]() - News- No mortality benefit after intensive glucose control once Hb A1c curves equalize- October 23, 2020- Is there a reduction in cardiovascular events in veterans with type 2 diabetes who were treated with intensive glucose control versus standard therapy at 15 years’ follow-up? 
![1]() - News- COVID-19 vaccine standards questioned at FDA advisory meeting- October 23, 2020- Speakers asked for data showing COVID-19 vaccines can prevent serious illness and urged transparency about the agency’s deliberations for each product to be considered. 
![1]() - News- CDC expands definition of COVID-19 exposure from ‘close contact’- October 23, 2020- Four factors associated with higher risk for transmission are the proximity of each encounter, its duration, whether an interaction takes place indoors or outdoors, and the number of people encountered. 
- News- COVID-19: Convalescent plasma falls short in phase 2 trial- October 22, 2020- Convalescent plasma may reduce viral load, hospital stay, and mortality, but randomized controlled trials to date have ended prematurely. 
![1]() - News- FDA approves remdesivir, first treatment for COVID-19- October 22, 2020- The FDA also issued a new EUA for remdesivir allowing treatment of hospitalized pediatric patients younger than 12 weighing at least 3.5 kg. 





